Singular Genomics Systems... (OMIC)
20.01
0.05 (0.25%)
At close: Feb 20, 2025, 3:59 PM
20.01
0.00%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 19.98 |
| Market Cap | 50.77M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -34.68 |
| PE Ratio (ttm) | -0.58 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 20.01 |
| Volume | 6,686 |
| Avg. Volume (20D) | 13,576 |
| Open | 20.00 |
| Previous Close | 19.96 |
| Day's Range | 20.00 - 20.01 |
| 52-Week Range | 5.34 - 23.41 |
| Beta | undefined |
About OMIC
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, s...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date May 27, 2021
Employees 255
Stock Exchange NASDAQ
Ticker Symbol OMIC
Website https://singulargenomics.com
Analyst Forecast
According to 2 analyst ratings, the average rating for OMIC stock is "Hold." The 12-month stock price forecast is $10.75, which is a decrease of -46.28% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
Singular Genomics Systems Inc. is scheduled to release its earnings on Mar 17, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+119.12%
Singular Genomics shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago
-0.35%
Singular Genomics shares are trading higher after the company announced it received a non-binding acquisition proposal from Deerfield
